Cargando…

KSI-301: antibody biopolymer conjugate in retinal disorders

KSI-301 is a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of age-related macular degeneration (AMD), diabetic macular oedema (DME) and retinal vein occlusion (RVO). Preclinical and early clinical trials so far hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrasekaran, Priya R., Madanagopalan, V.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278447/
https://www.ncbi.nlm.nih.gov/pubmed/34291186
http://dx.doi.org/10.1177/25158414211027708

Ejemplares similares